Vasculoprotective effects of somatostatin receptor subtypes

Molecular and Cellular Endocrinology

Volumn 279, Issue 1-2, 2007, Pages 34-38

  Tigerstedt, Nina Maria ^a   Aavik, Einari ^a   Aavik, Silja ^a   Savolainen Peltonen, Hanna ^a   Hayry, Pekka ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

(Rat aortic) tissue explant; (Rat carotid) arterial injury; Smooth muscle cell; Somatostatin analogs; Somatostatin receptor

Indexed keywords

CARDIOVASCULAR AGENT; L 779976; L 796778; L 797591; L 803087; SOMATOSTATIN RECEPTOR 1 AGONIST; SOMATOSTATIN RECEPTOR 2 AGONIST; SOMATOSTATIN RECEPTOR 3 AGONIST; SOMATOSTATIN RECEPTOR 4 AGONIST; SOMATOSTATIN RECEPTOR 5 AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; BLOOD VESSEL WALL; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; EXPLANT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA; MALE; MEMBRANE PROTEINS; ORGAN CULTURE TECHNIQUES; PEPTIDES; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TUNICA INTIMA;

EID: 35649005900     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.08.018     Document Type: Article

References (16)

1. Aavik E., Luoto N.M., Petrov L., Aavik S., Patel Y.C., and Hayry P. Elimination of vascular fibrointimal hyperplasia by somatostatin receptor 1.4 selective agonist. FASEB J. 16 (2002) 724-726
2. Clowes A.W., Reidy M.A., and Clowes M.M. Mechanisms of stenosis after arterial injury. Lab. Invest. 49 (1983) 208-215
3. Curtis S.B., Hewitt J., Yakubovitz S., Anzarut A., Hsiang Y.N., and Buchan A.M. Somatostatin receptor subtype expression and function in human vascular tissue. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1815-H1822
4. Emanuelsson H., Beatt K.J., Bagger J.P., Balcon R., Heikkila J., Piessens J., Schaeffer M., Suryapranta H., and Foegh M. Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group. Circulation 91 (1995) 1689-1696
5. Eriksen U.H., Amtorp O., Bagger J.P., Emanuelsson H., Foegh M., Henningsen P., Saunamaki K., Schaeffer M., Thayssen P., and Orskov H. Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am. Heart J. 30 (1995) 1-8
6. Khare S., Kumar U., Sasi R., Puebla L., Calderon L., Lemstrom K., Hayry P., and Patel Y.C. Differential regulation of somatostatin receptor types 1-5 in rat aorta after angioplasty. FASEB J. 13 (1999) 387-394
7. Lundegan C., Foegh M.L., Vargas R., Eufemio M., Bormes G.W., and Kot P.A. Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Atherosclerosis 80 (1989) 49-55
8. Moller L.N., Stidsen C.E., Hartmann B., and Holst J.J. Somatostatin receptors. Biochim. Biophys. Acta 1616 (2003) 1-84
9. Myllarniemi M., Calderon L., Lemstrom K., Buchdunger E., and Hayry P. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. FASEB J. 11 (1997) 1119-1126
10. Olias G., Viollet C., Kusserow H., Epelbaum J., and Meyerhof W. Regulation and function of somatostatin receptors. J. Neurochem. 89 (2004) 1057-1091
11. Patel Y.C. Somatostatin and its receptor family. Front. Neuroendocrinol. 20 (1999) 157-198
12. Reisine T., and Bell G.I. Molecular biology of somatostatin receptors. Endocr. Rev. 16 (1995) 427-442
13. Rohrer S.P., Birzin E.T., Mosley R.T., Berk S.C., Hutchins S.M., Shen D.M., Xiong Y., Hayes E.C., Parmar R.M., Foor F., Mitra S.W., Degrado S.J., Shu M., Klopp J.M., Cai S.J., Blake A., Chan W.W., Pasternak A., Yang L., Patchett A.A., Smith R.G., Chapman K.T., and Schaeffer J.M. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282 (1998) 737-740
14. Sata M., Saiura A., Kunisato A., Tojo A., Okada A., Tokuhisa T., Hirai H., Makuuchi M., Hirata Y., and Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8 (2002) 403-409
15. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int. Rev. Cytol. 169 (1996) 183-265
16. von Essen R., Ostermaier R., Grube E., Maurer W., Tebbe U., Erbel R., Roth M., Oel W., Brom J., and Weidinger G. Effects of octreotide treatment on restenosis after coronary angioplasty: results of the VERAS study. VErringerung der Restenoserate nach Angioplastie durch ein Somatostatin-analogon. Circulation 96 (1997) 1482-1487